THE CELL THEATRE COMPANY LTD
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$90,601
Cash & Equivalents
51%
Property, Plant, & Equipment (net)
30%
Inventories
17%
Receivables (Non-Related)
1%
Related-Party Receivables
0%
Prepaid Expenses
0%
Investments
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$25,489
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$26,830
$46,574
+74%
Receivables (Non-Related)
-
$952
-
Related-Party Receivables
-
-
-
Inventories
$11,229
$15,610
+39%
Prepaid Expenses
$0
-
-
Investments
-
-
-
Property, Plant, & Equipment (net)
$24,163
$27,465
+14%
Other Assets
-
-
-
Total Assets
$62,222
$90,601
+46%
Liabilities
2023
2024
Change
Payables & Accruals
$10,997
$25,489
+132%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$4,995
$0
-100%
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$15,992
$25,489
+59%
Net assets
2023
2024
Change
Restricted Net Assets
$10,005
$46,755
+367%
Unrestricted Net Assets
$36,225
$18,357
-49%
Net assets
2023
2024
Change
Net assets
+$46,230
+$65,112
+41%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)